Cho Rong Han

492 citations
19 papers · 392 indexed · h-index 13
Topics
Cell death mechanisms and regulation (6 papers)Thyroid Disorders and Treatments (5 papers)Bioactive Compounds and Antitumor Agents (3 papers)

In The Last Decade

Cho Rong Han

19 papers receiving 382 citations

Peers

Cho Rong Han
Comparison fields: 5 of 68
  • Molecular Biology 234
  • Oncology 63
  • Cell Biology 60
  • Epidemiology 57
  • Endocrinology, Diabetes and Metabolism 57
Replace Sudha Govind with:
Sudha Govind United States
Qin Deng China
Young-Hee Kang South Korea
Nathália G. Amado Brazil
Pınar Obakan Yerlikaya Türkiye
Yashin Sreenivasan India
Gosukonda Subrahmanyam India
Tatsuya Kaneshiro Japan
Lee‐Yong Khil South Korea
Cho Rong Han relative to Sudha Govind United States Sudha Govind's profile →
Citations per field
00.5×1.5×2.1×
Sudha Govind · 1×
Citations per year

Countries citing papers authored by Cho Rong Han

Since Specialization
Citations

This map shows the geographic impact of Cho Rong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho Rong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho Rong Han more than expected).

Fields of papers citing papers by Cho Rong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho Rong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho Rong Han. The network helps show where Cho Rong Han may publish in the future.

Co-authorship network of co-authors of Cho Rong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Cho Rong Han. A scholar is included among the top collaborators of Cho Rong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho Rong Han. Cho Rong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 5
2 21
3 14
4 13
5 8
6 23
7 5
8 16
9 37
10 1
11 23
12 25
13 4
14 15
15 14
16 67
17 23
18 4
19 74

About Cho Rong Han

Cho Rong Han is a scholar working on Toxicology, Endocrinology, Diabetes and Metabolism and Complementary and alternative medicine, having authored 19 papers that have together received 392 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Thyroid Disorders and Treatments (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (35 citations), Cell Biology (60 citations) and Endocrinology, Diabetes and Metabolism (57 citations). Cho Rong Han has collaborated with scholars based in South Korea, United States and Macao. Frequent co-authors include Do Youn Jun, Young Ho Kim, Sheue-yann Cheng, Hyun Ju Woo, Ji Young Lee, Li Zhao, Jeong Won Park, Mark C. Willingham, J. S. Kim and Hae‐Sim Park. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026